Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuting Lu

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Cell Metabolism|October 6, 2021
DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicingYufeng Li, Junyu Xu, Yuting Lu, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Longitudinal Impact of WTC Dust Inhalation on Rat Cardiac Tissue Transcriptomic ProfilesSung-Hyun Park, Yuting Lu, Yongzhao Shao, et al.
Annals of Internal Medicine|September 22, 2025
Palliative Care Educational App for Family Caregivers of Homebound Patients With Incurable Cancer : A Single-Center Randomized TrialYing Yu, Hao Xue, Chen Suo, et al.
Frontiers in Immunology|July 25, 2022
Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor ProgressionYuhan Wei, Jianwei Zhang, Xueke Fan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 20, 2023
Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia-Reperfusion InjuryQingchun Mu, Kai Yao, Madiha Zahra Syeda, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 23, 2024
Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke TheranosticsQingchun Mu, Kai Yao, Madiha Zahra Syeda, et al.
Liver Cancer|June 24, 2026
Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup AnalysisMasatoshi Kudo, Atsushi Hiraoka, Kazushi Numata, et al.
Cell Reports|November 15, 2024
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanomaYuting Lu, Jana Travnickova, Mihaly Badonyi, et al.
Cell Reports|July 4, 2024
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanomaYuting Lu, Jana Travnickova, Mihaly Badonyi, et al.
Clinical and Translational Medicine|April 27, 2022
Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantationZhiyong Guo, Jinghong Xu, Shanzhou Huang, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Cell Metabolism|October 6, 2021
DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicingYufeng Li, Junyu Xu, Yuting Lu, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Longitudinal Impact of WTC Dust Inhalation on Rat Cardiac Tissue Transcriptomic ProfilesSung-Hyun Park, Yuting Lu, Yongzhao Shao, et al.
Annals of Internal Medicine|September 22, 2025
Palliative Care Educational App for Family Caregivers of Homebound Patients With Incurable Cancer : A Single-Center Randomized TrialYing Yu, Hao Xue, Chen Suo, et al.
Frontiers in Immunology|July 25, 2022
Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor ProgressionYuhan Wei, Jianwei Zhang, Xueke Fan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 20, 2023
Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia-Reperfusion InjuryQingchun Mu, Kai Yao, Madiha Zahra Syeda, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 23, 2024
Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke TheranosticsQingchun Mu, Kai Yao, Madiha Zahra Syeda, et al.
Liver Cancer|June 24, 2026
Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup AnalysisMasatoshi Kudo, Atsushi Hiraoka, Kazushi Numata, et al.
Cell Reports|November 15, 2024
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanomaYuting Lu, Jana Travnickova, Mihaly Badonyi, et al.
Cell Reports|July 4, 2024
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanomaYuting Lu, Jana Travnickova, Mihaly Badonyi, et al.
Clinical and Translational Medicine|April 27, 2022
Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantationZhiyong Guo, Jinghong Xu, Shanzhou Huang, et al.
Pageof 22